Ultragenyx Pharmaceutical, Inc. (RARE)
36.30
-0.15
(-0.41%)
USD |
NASDAQ |
Dec 09, 16:00
36.49
+0.19
(+0.52%)
After-Hours: 06:56
Ultragenyx Pharmaceutical Market Cap: 3.502B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 72.79B |
| Amicus Therapeutics, Inc. | 3.027B |
| Geron Corp. | 785.18M |
| Ionis Pharmaceuticals, Inc. | 12.77B |
| Vertex Pharmaceuticals, Inc. | 110.88B |
Market Cap Related Metrics
| PS Ratio | 5.615 |
| Price to Book Value | 382.37 |
| Price | 36.30 |
| Earnings Yield | -16.36% |